GeorgePeterCanellosMD

PubMed

• Joseph R. Bertino, Scientist and Clinical Oncologist.
  Bruce A Chabner, George P Canellos> ;Journal of Clinical Oncology. 2022 May 10
• 2 citations
  Combination chemotherapy of solid tumors: an American-Italian collaboration: a celebration of the work of Gianni Bonadonna.
  Vincent T. DeVita, George P. Canellos> ;Tumori. 2016 Mar 22
• Gianni Bonadonna (1934–2015)
  George P. Canellos, V T DeVita> ;Leukemia & Lymphoma. 2016 Jan 11
• Gianni Bonadonna: A Personal Remembrance
  George P. Canellos, V T DeVita> ;The Oncologist. 2015 Nov 1
• 118 citations
  In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
  Ayalew Tefferi, Hagop M. Kantarjian, S. Vincent Rajkumar, Larry Baker, J L Abkowitz, John W. Adamson, Ranjana H. Advani, James P. Allison, Karen H. Antman, Robert C. B...> ;Mayo Clinic Proceedings. 2015 Aug 1
• Advanced DLBCL: as systemic therapy improves, the need for RT diminishes.
  George P. Canellos> ;Oncology. 2014 Dec 1
• 113 citations
  Treatment of Hodgkin Lymphoma: A 50-Year Perspective
  George P. Canellos, Saul A. Rosenberg, Jonathan W. Friedberg, T. Andrew Lister, Vincent T. DeVita> ;Journal of Clinical Oncology. 2014 Jan 20
• Treatment for favorable localized Hodgkin lymphoma: the final answer is awaited.
  George P. Canellos> ;Oncology. 2012 Dec 18
• 8 citations
  Brentuximab Vedotin and Panobinostat: New Drugs for Hodgkin's Lymphoma—Can They Make One of Medical Oncology's Chemotherapy Success Stories More Successful?
  George P. Canellos> ;Journal of Clinical Oncology. 2012 Jun 20
• 137 citations
  A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype
  Wyndham H. Wilson, Sin-Ho Jung, Pierluigi Porcu, David D. Hurd, Jeffrey L. Johnson, S. Eric Martin, Myron S. Czuczman, Raymond Lai, Jonathan W. Said, Amy Chadburn, Dan...> ;Haematologica. 2012 May 1
• 33 citations
  Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and ...
  Lale Kostakoglu, Heiko Schöder, Jeffrey L. Johnson, Nathan Hall, Lawrence H. Schwartz, David J. Straus, Ann S. LaCasce, Sin-Ho Jung, Nancy L. Bartlett, George P. Canel...> ;Leukemia & Lymphoma. 2012 Mar 15
• 49 citations
  Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.
  David J. Straus, Jeffrey L. Johnson, Ann S. LaCasce, Nancy L. Bartlett, Lale Kostakoglu, Eric D. Hsi, Heiko Schöder, Nathan Hall, Sin-Ho Jung, George P. Canellos, Lawr...> ;Blood. 2011 May 19
• 2 citations
  Can Low-Risk, Early-Stage Patients with Hodgkin Lymphoma Be Spared Radiotherapy?
  Gregory M. Cote, George P. Canellos> ;Current Hematologic Malignancy Reports. 2011 Apr 19
• 80 citations
  End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma
  Jeffrey A. Barnes, Ann S. LaCasce, Katherine Zukotynski, David Israel, Yang Feng, Donna Neuberg, Christiana E. Toomey, Ephraim P. Hochberg, George P. Canellos, Jeremy ...> ;Annals of Oncology. 2011 Apr 1
• 7 citations
  Hematology in 2010: New therapies and standard of care in oncology
  Vincent T. DeVita, George P. Canellos> ;Nature Reviews. Clinical Oncology. 2011 Jan 31
• Reply to M. Ozsahin et al.
  Canellos, G.P.> ;J Clin Oncol. 2010-08-16
• 42 citations
  Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma With Chemotherapy Without Consolidation by Radiation Therapy
  George P. Canellos, Jeremy S. Abramson, David C. Fisher, Ann S. LaCasce> ;Journal of Clinical Oncology. 2010 Mar 20
• 28 citations
  What Is the Appropriate Systemic Chemotherapy for Lymphocyte-Predominant Hodgkin's Lymphoma?
  George P. Canellos, Peter Mauch> ;Journal of Clinical Oncology. 2010 Jan 1
• 163 citations
  Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909
  Lloyd E. Damon, Jeffrey L. Johnson, Donna Niedzwiecki, Bruce D. Cheson, David D. Hurd, Nancy L. Bartlett, Ann S. LaCasce, Kristie A. Blum, John C. Byrd, Michael Kelly,...> ;Journal of Clinical Oncology. 2009 Dec 20
• 30 citations
  Long-term follow-up of survival in Hodgkin's lymphoma.
  George P. Canellos, Donna Niedzwiecki, Jeffrey L. Johnson> ;The New England Journal of Medicine. 2009 Dec 16
• 2 citations
  Is Chemotherapy Alone for Early Hodgkin Lymphoma an Emerging Therapeutic Option
  George P. Canellos> ;The Oncologist. 2009 Dec 1
• 6 citations
  Recombinant interferon-α2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691
  Sonali M. Smith, J Johnson, B D Cheson, George P. Canellos, G Petroni, M. M. Oken, David B. Duggan, David D. Hurd, John P. Gockerman, Barbara A. Parker, J Prchal, Bruc...> ;Leukemia & Lymphoma. 2009 Oct 8
• 87 citations
  Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Redu...
  Philippe Armand, Supriya Gannamaneni, Haesook T. Kim, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Ann S. LaCasce, Eric D. Jacobsen, David C. Fisher, Jenn...> ;Journal of Clinical Oncology. 2008 Dec 10
• 1 citations
  What constitutes "improved prognosis"?
  George P. Canellos> ;Journal of Clinical Oncology. 2008 Apr 20
• 105 citations
  Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.
  Philippe Armand, Haesook T. Kim, Vincent T. Ho, Corey Cutler, John Koreth, Joseph H. Antin, Ann S. LaCasce, Eric D. Jacobsen, David C. Fisher, Jennifer R. Brown, Georg...> ;Biology of Blood and Marrow Transplantation. 2008 Apr 1
• Join now to see all

Other

• Hematopoietic cell transplantation in classical Hodgkin lymphoma 
  Canellos GP, Mauch PM
  http://www.uptodate.com/contents/hematopoietic-cell-transplantation-in-classical-hodgkin-lymphoma
  UpToDate, Wolters Kluwer Health - 2012-04-19
• Staging and prognosis of Hodgkin lymphoma 
  Canellos GP, Mauch PM
  http://www.uptodate.com/contents/staging-and-prognosis-of-hodgkin-lymphoma
  UpToDate, Wolters Kluwer Health - 2012-11-02
• Overview of the treatment of classical Hodgkin lymphoma in adults 
  Canellos GP, Mauch PM
  http://www.uptodate.com/contents/overview-of-the-treatment-of-classical-hodgkin-lymphoma-in-adults
  UpToDate, Wolters Kluwer Health - 2012-07-26
• Relapse of classical Hodgkin lymphoma after initial radiotherapy 
  Canellos GP, Mauch PM
  http://www.uptodate.com/contents/relapse-of-classical-hodgkin-lymphoma-after-initial-radiotherapy
  UpToDate, Wolters Kluwer Health - 2012-04-17
• Second and third line chemotherapy regimens and biologic therapy for relapsing or resistant classical Hodgkin lymphoma 
  Canellos GP
  http://www.uptodate.com/contents/second-and-third-line-chemotherapy-regimens-and-biologic-therapy-fo
  UpToDate, Wolters Kluwer Health - 2013-03-29
• Treatment of relapse of classical Hodgkin lymphoma after initial chemotherapy 
  Canellos GP, Mauch PM
  http://www.uptodate.com/contents/treatment-of-relapse-of-classical-hodgkin-lymphoma-after-initial-ch
  UpToDate, Wolters Kluwer Health - 2013-01-31
• Join now to see all